MENU
ATHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Athira Pharma (ATHA) Ownership - Who owns Athira Pharma?
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Profile
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.1M
P/E Ratio
N/A
Total Cash
51.28M
Projected Growth
N/A
Total Debt
1.22M
Revenue
N/A
Risk (Beta)
2.84
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHA
Capitalization
11.1M
P/E Ratio
N/A
Risk (Beta)
2.84
Dividend Yield
N/A
Total Cash
51.3M
Total Cash/Share
1.31
Total Debt
1.22M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
44.8M
P/B Ratio
0.25
Cash Flow
N/A
Earnings
-2.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
4.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-95.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-88.52
Shares Held By Institutions
11M
Shares Outstanding - Current
39M
Total Liabilities
13.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-51.543
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com